S&P 500   3,669.01 (+0.18%)
DOW   29,883.79 (+0.20%)
QQQ   303.67 (+0.07%)
AAPL   123.09 (+0.30%)
MSFT   214.93 (-0.59%)
FB   287.10 (+0.19%)
GOOGL   1,823.32 (+1.56%)
AMZN   3,202.37 (-0.55%)
TSLA   569.30 (-2.64%)
NVDA   541.83 (+1.16%)
BABA   261.08 (-1.11%)
CGC   28.13 (+5.55%)
GE   10.42 (+2.66%)
MU   69.20 (+3.16%)
AMD   93.75 (+1.21%)
T   29.08 (+0.73%)
NIO   47.89 (+5.58%)
F   9.19 (-0.54%)
ACB   10.90 (+11.79%)
NFLX   502.08 (-0.50%)
BA   223.79 (+5.06%)
GILD   61.21 (+0.15%)
DIS   153.50 (+2.72%)
S&P 500   3,669.01 (+0.18%)
DOW   29,883.79 (+0.20%)
QQQ   303.67 (+0.07%)
AAPL   123.09 (+0.30%)
MSFT   214.93 (-0.59%)
FB   287.10 (+0.19%)
GOOGL   1,823.32 (+1.56%)
AMZN   3,202.37 (-0.55%)
TSLA   569.30 (-2.64%)
NVDA   541.83 (+1.16%)
BABA   261.08 (-1.11%)
CGC   28.13 (+5.55%)
GE   10.42 (+2.66%)
MU   69.20 (+3.16%)
AMD   93.75 (+1.21%)
T   29.08 (+0.73%)
NIO   47.89 (+5.58%)
F   9.19 (-0.54%)
ACB   10.90 (+11.79%)
NFLX   502.08 (-0.50%)
BA   223.79 (+5.06%)
GILD   61.21 (+0.15%)
DIS   153.50 (+2.72%)
S&P 500   3,669.01 (+0.18%)
DOW   29,883.79 (+0.20%)
QQQ   303.67 (+0.07%)
AAPL   123.09 (+0.30%)
MSFT   214.93 (-0.59%)
FB   287.10 (+0.19%)
GOOGL   1,823.32 (+1.56%)
AMZN   3,202.37 (-0.55%)
TSLA   569.30 (-2.64%)
NVDA   541.83 (+1.16%)
BABA   261.08 (-1.11%)
CGC   28.13 (+5.55%)
GE   10.42 (+2.66%)
MU   69.20 (+3.16%)
AMD   93.75 (+1.21%)
T   29.08 (+0.73%)
NIO   47.89 (+5.58%)
F   9.19 (-0.54%)
ACB   10.90 (+11.79%)
NFLX   502.08 (-0.50%)
BA   223.79 (+5.06%)
GILD   61.21 (+0.15%)
DIS   153.50 (+2.72%)
S&P 500   3,669.01 (+0.18%)
DOW   29,883.79 (+0.20%)
QQQ   303.67 (+0.07%)
AAPL   123.09 (+0.30%)
MSFT   214.93 (-0.59%)
FB   287.10 (+0.19%)
GOOGL   1,823.32 (+1.56%)
AMZN   3,202.37 (-0.55%)
TSLA   569.30 (-2.64%)
NVDA   541.83 (+1.16%)
BABA   261.08 (-1.11%)
CGC   28.13 (+5.55%)
GE   10.42 (+2.66%)
MU   69.20 (+3.16%)
AMD   93.75 (+1.21%)
T   29.08 (+0.73%)
NIO   47.89 (+5.58%)
F   9.19 (-0.54%)
ACB   10.90 (+11.79%)
NFLX   502.08 (-0.50%)
BA   223.79 (+5.06%)
GILD   61.21 (+0.15%)
DIS   153.50 (+2.72%)
Log in
NASDAQ:TLGT

Teligent Stock Forecast, Price & News

$0.54
0.00 (0.00 %)
(As of 12/2/2020 03:47 PM ET)
Add
Compare
Today's Range
$0.51
Now: $0.54
$0.54
50-Day Range
$0.48
MA: $0.59
$1.05
52-Week Range
$0.46
Now: $0.54
$6.90
Volume51,291 shs
Average Volume724,977 shs
Market Capitalization$2.91 million
P/E RatioN/A
Dividend YieldN/A
Beta1.68
Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. The company's topical semi-solid and liquid products are used in various applications that range from cosmetics and cosmeceuticals; and the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. It sells its products through national chain drug stores, drug wholesalers, distributors, and group purchasing organizations. The company was formerly known as IGI Laboratories, Inc. and changed its name to Teligent, Inc. in October 2015. Teligent, Inc. was founded in 1977 and is based in Buena, New Jersey.
Teligent logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.20 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TLGT
CUSIPN/A
Phone856-697-1441
Employees252

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$65.90 million
Book Value($0.99) per share

Profitability

Net Income$-25,120,000.00

Miscellaneous

Market Cap$2.91 million
Next Earnings Date12/7/2020 (Estimated)
OptionableOptionable
$0.54
0.00 (0.00 %)
(As of 12/2/2020 03:47 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TLGT News and Ratings via Email

Sign-up to receive the latest news and ratings for TLGT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Teligent (NASDAQ:TLGT) Frequently Asked Questions

How has Teligent's stock price been impacted by Coronavirus (COVID-19)?

Teligent's stock was trading at $3.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, TLGT shares have decreased by 84.0% and is now trading at $0.5209.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Teligent?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teligent in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Teligent
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Teligent?

Wall Street analysts have given Teligent a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Teligent wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Teligent's next earnings date?

Teligent is scheduled to release its next quarterly earnings announcement on Monday, December 7th 2020.
View our earnings forecast for Teligent
.

How were Teligent's earnings last quarter?

Teligent, Inc. (NASDAQ:TLGT) issued its quarterly earnings data on Wednesday, August, 19th. The company reported ($1.54) earnings per share for the quarter, beating the Zacks' consensus estimate of ($1.70) by $0.16. The firm had revenue of $13.59 million for the quarter.
View Teligent's earnings history
.

When did Teligent's stock split? How did Teligent's stock split work?

Teligent shares reverse split on the morning of Thursday, May 28th 2020. The 1-10 reverse split was announced on Wednesday, May 27th 2020. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, May 27th 2020. An investor that had 100 shares of Teligent stock prior to the reverse split would have 10 shares after the split.

What price target have analysts set for TLGT?

1 equities research analysts have issued 1 year target prices for Teligent's stock. Their forecasts range from $2.00 to $2.00. On average, they expect Teligent's share price to reach $2.00 in the next year. This suggests a possible upside of 284.0% from the stock's current price.
View analysts' price targets for Teligent
.

Are investors shorting Teligent?

Teligent saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 1,450,000 shares, an increase of 94.8% from the October 31st total of 744,500 shares. Based on an average trading volume of 2,140,000 shares, the short-interest ratio is currently 0.7 days. Currently, 27.5% of the company's shares are short sold.
View Teligent's Short Interest
.

Who are some of Teligent's key competitors?

What other stocks do shareholders of Teligent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teligent investors own include Novavax (NVAX), ChemoCentryx (CCXI), Voyager Therapeutics (VYGR), AbbVie (ABBV), General Electric (GE), Biocept (BIOC), Lannett (LCI), Pfizer (PFE), Selecta Biosciences (SELB) and VBI Vaccines (VBIV).

Who are Teligent's key executives?

Teligent's management team includes the following people:
  • Mr. Timothy B. Sawyer, Pres, CEO & Director (Age 55)
  • Mr. Antonio Di Nicola, GM & VP of Operations
  • Ms. Nadya Lawrence, Sr. VP of Technical Services (Age 51, Pay $186.63k)
  • Mr. Philip K. Yachmetz, Chief Legal Officer & Corp. Sec. (Age 63)
  • Mr. Mark Mantel, VP of Sales & Marketing and GM of Canada
  • Ms. Justine Kostka, Assistant Controller (Age 66)
  • Dr. Subhash Saxena, Technical Consultant and Member of Scientific Advisory Board

What is Teligent's stock symbol?

Teligent trades on the NASDAQ under the ticker symbol "TLGT."

Who are Teligent's major shareholders?

Teligent's stock is owned by many different retail and institutional investors. Top institutional investors include Morgan Stanley (8.10%). Company insiders that own Teligent stock include Bhaskar Chaudhuri, Carole Ben-Maimon, Damian Finio, James C Gale, Jason Grenfell-Gardner, Sciences Opportunities Fu Life and Stephen Richardson.
View institutional ownership trends for Teligent
.

Which major investors are selling Teligent stock?

TLGT stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley.
View insider buying and selling activity for Teligent
.

How do I buy shares of Teligent?

Shares of TLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Teligent's stock price today?

One share of TLGT stock can currently be purchased for approximately $0.52.

How big of a company is Teligent?

Teligent has a market capitalization of $2.81 million and generates $65.90 million in revenue each year. Teligent employs 252 workers across the globe.

What is Teligent's official website?

The official website for Teligent is www.teligent.com.

How can I contact Teligent?

Teligent's mailing address is 105 LINCOLN AVENUE, BUENA NJ, 08310. The company can be reached via phone at 856-697-1441 or via email at [email protected]

This page was last updated on 12/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.